Alumis (ALMS) Metrics: History & Chart

Alumis Inc.(ALMS)

Biotechnology · South San Francisco, CA

$6.72-0.13 (-1.83%)

Delayed quote: Oct 6, 2026, 10:05 AM EDT

About Alumis Inc.

Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. The company offers envudeucitinib, a tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis and systemic lupus erythematosus; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor that is in Phase 1 for the treatment of neuroinflammatory and neurodegenerative diseases. It also develops lonigutamab, a monoclonal antibody targeting IGF-1R for the treatment of thyroid eye diseases; and interferon regulatory factor 5 (IRF5) to address immune dysfunction. The company was formerly known as Esker Therapeutics, Inc. and changed its name to Alumis Inc. in January 2022. Alumis Inc. was incorporated in 2021 and is headquartered in South San Francisco, California.

South San Francisco, CA

237 employees

www.alumis.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Martin Babler

View full financials

Third-Party DCF Estimate (FMP)	$0.88
Price Gap vs Third-Party Estimate	-87.21%

7D Total Return	-4.47%
30D Total Return	-38.38%
YTD Total Return	-29.92%
1Y Total Return	+70.15%
3Y Total Return	N/A
5Y Total Return	N/A
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	-29.92%
2025	+24.17%
2024	N/A
2023	N/A
2022	N/A
2021	N/A

CAGR TTM	+69.72%
CAGR 3Y	N/A
CAGR 5Y	N/A
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

ALMS Valuation Metrics

ALMS Stock Price Metrics

ALMS Dividend Metrics

ALMS Growth Rate Metrics

ALMS Discounted Cash Flow Metrics

ALMS Returns By Period

ALMS Yearly Returns

ALMS Average Annual Returns By Period (CAGR)

ALMS Revenue Metrics

ALMS PE Ratio Metrics

ALMS PS Ratio Metrics

ALMS PB Ratio Metrics

ALMS Price to Free Cash Flow Ratio Metrics

ALMS Debt to Equity Ratio Metrics

ALMS PEG Ratio Metrics

ALMS FCF Yield

ALMS Earnings Yield

ALMS EBITDA Yield

ALMS OCF Yield

ALMS EV/EBIT Ratio Metrics

ALMS EV/EBITDA Ratio Metrics

ALMS EV/Assets Ratio Metrics

ALMS EV/Sales Ratio Metrics

ALMS Current Ratio Metrics

ALMS Quick Ratio Metrics

ALMS ROIC Metrics

ALMS Return on Assets Metrics

ALMS Return on Equity Metrics

ALMS Net Profit Margin Metrics

ALMS Gross Profit Margin Metrics

ALMS Tax Rate Metrics

PS Ratio	118.06
PS Ratio Avg TTM	174.59
PS Ratio Avg 3Y	74.06
Current VS TTM Avg	-32.38%
Current VS 3Y Avg	+59.40%
Current VS 5Y Avg	+59.40%

PB Ratio	1.93
PB Ratio Avg TTM	5.06
PB Ratio Avg 3Y	3.19
Current VS TTM Avg	-61.84%
Current VS 3Y Avg	-39.48%
Current VS 5Y Avg	-39.48%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.08
Debt/Equity Ratio Avg TTM	0.09
Debt/Equity Ratio Avg 3Y	0.05
Current VS TTM Avg	-9.30%
Current VS 3Y Avg	+77.58%
Current VS 5Y Avg	+91.24%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	1.51
Ev/Assets Ratio Avg TTM	3.92
Ev/Assets Ratio Avg 3Y	2.29
Current VS TTM Avg	-61.51%
Current VS 3Y Avg	-34.09%
Current VS 5Y Avg	-34.09%

Ev/Sales Ratio	114.37
Ev/Sales Ratio Avg TTM	171.82
Ev/Sales Ratio Avg 3Y	72.22
Current VS TTM Avg	-33.44%
Current VS 3Y Avg	+58.36%
Current VS 5Y Avg	+58.36%

Current Ratio	6.74
Current Ratio Avg TTM	6.13
Current Ratio Avg 3Y	4.63
Current VS TTM Avg	+10.00%
Current VS 3Y Avg	+45.62%
Current VS 5Y Avg	+41.27%

Quick Ratio	6.74
Quick Ratio Avg TTM	6.13
Quick Ratio Avg 3Y	4.63
Current VS TTM Avg	+10.00%
Current VS 3Y Avg	+45.62%
Current VS 5Y Avg	+41.27%

ROIC	(94.76%)
ROIC Avg 3Y	(114.40%)
ROIC Avg 5Y	(114.40%)
Current VS 3Y Avg	+17.17%
Current VS 5Y Avg	+17.17%
Current VS 10Y Avg	+17.17%

ROA	(78.30%)
ROA Avg TTM	(14.95%)
ROA Avg 3Y	(22.17%)
Current VS TTM Avg	-423.62%
Current VS 3Y Avg	-253.26%
Current VS 5Y Avg	-327.75%

ROE	(97.08%)
ROE Avg TTM	(66.06%)
ROE Avg 3Y	(89.49%)
Current VS TTM Avg	-46.96%
Current VS 3Y Avg	-8.48%
Current VS 5Y Avg	-8.48%

Net Profit Margin	(5933.45%)
Net Profit Margin Avg TTM	(4371.04%)
Net Profit Margin Avg 3Y	(1724.95%)
Current VS TTM Avg	-35.74%
Current VS 3Y Avg	-243.98%
Current VS 5Y Avg	-270.44%

Gross Profit Margin	88.23%
Gross Pft Margin Avg TTM	89.99%
Gross Pft Margin Avg 3Y	42.31%
Current VS TTM Avg	-1.96%
Current VS 3Y Avg	+108.55%
Current VS 5Y Avg	+124.60%

Tax Rate	(16.87%)
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A